Study Links Blood Type and Fertility

2010 | November, Naturopathic News

Study Links Blood Type and Fertility
Scientists at Yale and Albert Einstein College of Medicine confirm 10-year-old research of Dr. Peter D’Adamo.

Wilton, CT, October 27, 2010 In a study presented earlier this week at the American Society of Reproductive Medicine Conference in Denver, researchers at Yale and Albert Einstein College of Medicine measured levels of a chemical called follicle-stimulating hormone (FSH) in 560 women undergoing fertility treatments and found that those women with type O blood had chemical signs linked to low egg numbers.

The control group had an average age of 35 and those with O blood type were found to have higher levels of FSH – almost twice the levels of women with the blood type A antigen. This is significant as high levels of FSH are thought to be an indicator that a woman’s ovarian egg reserve is diminishing – which can reduce a woman’s chances of conception once a woman reaches her 30s and 40s.

Although researchers at Yale and Albert Einstein College of Medicine could not identify a specific reason for this association, Dr. Peter D’Adamo, a naturopathic physician and expert in the field of human blood groups, provided this insight, “A significant number of infertility cases are the result of immunologic hostility between a person’s blood type and the environment.”

Dr. D’Adamo has researched the connections between blood type, genetics, and disease susceptibility for more than 30 years and supported his findings with extensive scientific documentation. In his book, Eat Right for Your Baby, published in 2003, Dr. D’Adamo discussed the vital connection between blood type and fertility, pointing out that, “Type O’s tend to suffer from hormonal and metabolic disorders, which are a major impediment to fertility.” As nutrition has an overarching affect on health and hormonal stability, Dr. D’Adamo makes nutritional recommendations unique to each of the four human blood groups to promote fertility and a healthy pregnancy.

Advertisement

Current Issue

Table of Contents

Advertisement

Trending Articles

Metagenics Names Patrick Sly as CEO to Lead Next Chapter of Growth

Metagenics Names Patrick Sly as CEO to Lead Next Chapter of Growth

Aliso Viejo, CA – December 1, 2025 Metagenics, a leading  doctor-recommended professional supplement announced it has named Patrick Sly as CEO, effective immediately. A highly regarded executive in the health and wellness industry, Mr. Sly brings a wealth of...

FDA Removes Black Box Warnings from Hormone Replacement Therapy

FDA Removes Black Box Warnings from Hormone Replacement Therapy

New review of research shows benefits outweigh risks for women who start treatment within 10 years of menopause onset After more than two decades, the FDA is finally removing the black box warnings that have kept millions of women from accessing hormone replacement...

Naturopathic Doctor Continues Walk Across USA for Health Equity

Naturopathic Doctor Continues Walk Across USA for Health Equity

Fargo, ND - Dennis Godby, 69, ND, MA, a Sacramento, CA-Licensed Naturopathic Doctor (ND), to raise awareness across the USA of significant health disparities, and support the “Health Equity,” movement, will continue his inspiring 756 mile walking trek across America...

Custom Publishing

IS TYLENOL SAFE DURING PREGNANCY?

IS TYLENOL SAFE DURING PREGNANCY?

Understanding Risk Factors, Not Causation Learn how much Tylenol pregnant women can safely take, what risk factors matter, and why glutathione status—not acetaminophen itself—determines safety during pregnancy.   IN THIS ARTICLE • Key Takeaways: Tylenol Safety...

Featured News